Frankfurt
26.10.26 | 20:18
8,720 Euro
+3,81 % +0,320
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 8,550 | 9,190 | 26.10. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| NEXSTIM Aktie jetzt für 0€ handeln | |||||
| Fr | Nexstim Oyj: Nexstim Plc Business Update Q3 2026 | 140 | GlobeNewswire (Europe) | Press release, Helsinki, 23 October 2026 at 9 AM (EEST)
Nexstim Plc Business Update Q3 2026
Nexstim Plc ("Nexstim" or "Company") announces the key highlights of the Company's business operations during... ► Artikel lesen | |
| 14.10. | Nexstim Oyj: Nexstim and Brainlab Advance Neuroscience Capabilities in Portugal with Installation at Hospital da Luz Lisboa | 211 | GlobeNewswire (Europe) | Press Release, Helsinki, 14 October 2026 at 9 AM (EEST)
Nexstim and Brainlab Advance Neuroscience Capabilities in Portugal with Installation at Hospital da Luz Lisboa
Nexstim Plc (NXTMH:HEX) ("Nexstim"... ► Artikel lesen | |
| 09.10. | Original-Research: Nexstim Oyj (von NuWays AG): BUY | 458 | EQS Group (EN) | Original-Research: Nexstim Oyj - from NuWays AG
09.10.2026 / 09:00 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the... ► Artikel lesen | |
| 02.09. | Original-Research: Nexstim (von NuWays AG): BUY | 539 | EQS Group (EN) | Original-Research: Nexstim - from NuWays AG
02.09.2026 / 09:00 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content... ► Artikel lesen | |
| 02.09. | Stimulating growth with surgical accuracy; INITIATE with BUY: We initate Nexstim coverage with a BUY ... | 571 | NuWays | Nexstim is a Finnish MedTech company and a global leader in navigated transcranial magnetic stimulation (nTMS) technology. With nTMS, Nexstim helps (i) surgeons preserve patients' motor and speech cortices... ► Artikel lesen | |
| 21.08. | Nexstim Oyj: Nexstim Receives NBS 6 System Order for a European hospital and existing Nexstim customer | 272 | GlobeNewswire (Europe) | Press release, Helsinki, 21 August 2026 at 9 AM (EEST)
Nexstim Receives NBS 6 System Order for a European hospital and existing Nexstim customer
Nexstim Plc ("Nexstim" or "Company") has received an... ► Artikel lesen | |
| 14.08. | Nexstim meldet Umsatzwachstum für H1 2026 und Rekord-Auftragsbestand | 2 | Investing.com Deutsch | ||
| 14.08. | Nexstim Oyj: Nexstim Plc Half-year Report January 1 - June 30, 2026 (unaudited) | 251 | GlobeNewswire (Europe) | Company announcement, Helsinki, August 14, 2026 at 9 am (EEST)
NEXSTIM PLC HALF-YEAR REPORT JANUARY 1 - JUNE 30, 2026 (UNAUDITED)
NEXSTIM CONTINUED ITS GROWTH AND STRENGHTENED ITS FINANCIAL POSITION
The... ► Artikel lesen | |
| 14.07. | Nexstim Oyj: Nexstim Receives a New Order for Ten NBS 6 Systems from Distributor | 345 | GlobeNewswire (Europe) | Press Release, Helsinki, 14 July 2026 at 9 AM (EEST)
Nexstim Receives a New Order for Ten NBS 6 Systems from Distributor
Nexstim Plc ("Nexstim" or "Company") has received a new order for ten NBS 6 systems... ► Artikel lesen | |
| 13.05. | Nexstim Oyj: Inside Information: Nexstim Plc Announces EUR 5 Million Investment from Eiffel and from Brainlab and Conversion of Options by Certain Option Holders | 531 | GlobeNewswire (Europe) | Company Announcement, Helsinki, 13 May 2026 at 09:05 AM (EEST)
Inside Information: Nexstim Plc Announces EUR 5 Million Investment from Eiffel and from Brainlab and Conversion of Options by Certain... ► Artikel lesen | |
| 28.04. | Nexstim Oyj: Nexstim Plc Business Update Q1 2026 | 516 | GlobeNewswire (Europe) | Press release, Helsinki, 28 April 2026 at 9 AM (EEST)
Nexstim Plc Business Update Q1 2026
Nexstim Plc ("Nexstim" or "Company") announces the key highlights of the Company's business operations during... ► Artikel lesen | |
| 17.04. | Nexstim Oyj: Nexstim Plc establishes Restricted Share Unit plan for extended management team for earning periods 2026-2029 | 238 | GlobeNewswire (Europe) | Company Announcement, Helsinki, 17 April 2026 at 9 AM (EEST)
Nexstim Plc establishes Restricted Share Unit plan for extended management team for earning periods 2026-2029
The Board of Directors of Nexstim... ► Artikel lesen | |
| 30.03. | Nexstim Oyj: Nexstim Plc: Resolutions of the Annual General Meeting | 243 | GlobeNewswire (Europe) | Company Announcement, Helsinki, 30 March 2026 at 1:30 PM (EEST)
Nexstim Plc: Resolutions of the Annual General Meeting
Nexstim Plc ("Nexstim" or "Company") announces the following resolutions of the... ► Artikel lesen | |
| 23.03. | Nexstim Oyj: Nexstim's NBS System 6 gains FDA clearance for treatment of Obsessive Compulsive Disorder (OCD) | 452 | GlobeNewswire (Europe) | Press release, Helsinki, 23 March 2026 at 10:30 AM (EET)
Nexstim's NBS System 6 gains FDA clearance for treatment of Obsessive Compulsive Disorder (OCD)
Nexstim Plc ("Nexstim" or "Company") announces... ► Artikel lesen | |
| 26.02. | Nexstim Oyj: Nexstim Plc's Financial Statements Bulletin 2025 | 657 | GlobeNewswire (Europe) | Company announcement, Helsinki 26 February 2026 at 9 am (EET)
NEXSTIM PLC'S FINANCIAL STATEMENTS BULLETIN 2025
NEXSTIM ACCELERATED GROWTH AND ACHIEVED A PROFITABLE RESULT
January-December 2025
The... ► Artikel lesen | |
| 19.02. | Nexstim Oyj: Nexstim's NBS 6 system receives MDR certification in the EU for use in Post-Operative Rehabilitation | 304 | GlobeNewswire (Europe) | Press release, Helsinki, 19 February 2026 at 9 AM (EET)
Nexstim's NBS 6 system receives MDR certification in the EU for use in Post-Operative Rehabilitation
Nexstim Plc ("Nexstim" or "Company") has... ► Artikel lesen | |
| 16.02. | Nexstim Oyj: Nexstim Receives Clearance for its NBS 6 Diagnostics System in UAE | 657 | GlobeNewswire (Europe) | Press release, Helsinki, 16 February 2026 at 11:30 AM (EET)
Nexstim Receives Clearance for its NBS 6 Diagnostics System in UAE
Nexstim Plc ("Nexstim" or "Company") has received import clearance for... ► Artikel lesen | |
| 02.02. | Nexstim Oyj: Nexstim Receives System Order from Distributor in India | 433 | GlobeNewswire (Europe) | Press release, Helsinki, 2 February 2026 at 9 AM (EET)
Nexstim Receives System Order from Distributor in India
Nexstim Plc ("Nexstim" or "Company") has received an order for an NBS System 5 through... ► Artikel lesen | |
| 30.12.25 | Nexstim Oyj: US Customer Orders Two Nexstim NBS 6 Therapy Systems | 505 | GlobeNewswire (Europe) | Press release, Helsinki, 30 December 2025 at 9 AM (EET)
US Customer Orders Two Nexstim NBS 6 Therapy Systems
Nexstim Plc ("Nexstim" or "Company") has received an order for two NBS 6 therapy systems... ► Artikel lesen | |
| 23.12.25 | Nexstim Oyj: Inside information: Nexstim Plc Agrees on Next Phase of Exclusivity Agreement with Sinaptica Therapeutics, Inc. | 349 | GlobeNewswire (Europe) | Company Announcement, Helsinki, 23 December 2025 at 9 AM (EET)
Inside information: Nexstim Plc Agrees on Next Phase of Exclusivity Agreement with Sinaptica Therapeutics, Inc.
Nexstim Plc ("Nexstim"... ► Artikel lesen |
20 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc. - 8-K, Current Report | ||
| VERU | 2,210 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.10.2026 -5- | The following instruments on Boerse Frankfurt do have their last trading day on 02.10.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.10.2026ISIN NameUS75973T2006 RENALYTIX... ► Artikel lesen | |
| NYXOAH | 0,718 | 0,00 % | Nyxoah to Release Third Quarter 2026 Financial Results on November 5, 2026 | ||
| OPTOMED | 1,398 | +2,34 % | Optomed Oyj: Half-year report January - June 2026 | Optomed Plc Stock Exchange Release 14 August 2026 at 9.00, Helsinki
Optomed Plc: Half-year report January - June 2026
April - June 2026
Revenue decreased by 8.6 percent to EUR 3.5 (3.8) million.
Currency-adjusted... ► Artikel lesen | |
| MODULIGHT | 1,050 | +11,23 % | Modulight Oyj: Modulight's profitability improved significantly - order intake among the strongest in the company's history | Modulight Corporation | Company Release | October 23, 2026 at 10:30:00 EEST
This release is a summary of Modulight's interim report for January-September 2026. The whole report is attached to this stock... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 42,290 | +1,03 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,750 | +0,72 % | UBS stuft FMC FRESENIUS MEDICAL CARE AG auf 'Sell' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat FMC auf "Sell" mit einem Kursziel von 36 Euro belassen. Die anstehenden Quartalszahlen des Dialysespezialisten dürften angesichts der negativen... ► Artikel lesen | |
| FRESENIUS | 46,455 | +0,77 % | JPMORGAN stuft Fresenius SE auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - JPMorgan hat Fresenius nach Gesprächen mit der Investor-Relations-Abteilung mit einem Kursziel von 55,20 Euro auf "Overweight" belassen. Die Aktien stehen zudem auf der... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 13,060 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| GERRESHEIMER | 33,000 | +5,30 % | Kurssprünge und neue Aufträge: Wie belastbar ist die Wende? dynaCERT, Gerresheimer, Steyr Motors | Ein Übernahmeangebot, internationale Vertriebsfortschritte und ein Konzernumbau bringen Bewegung in die folgenden drei Börsenwerte. Während Anleger auf neue Wachstumsimpulse und finanzielle Entlastung... ► Artikel lesen | |
| HEARTFLOW | 57,01 | 0,00 % | Piper Sandler raises HeartFlow stock price target on competitive moat | ||
| BRIGHTSPRING HEALTH SERVICES | 58,93 | +0,08 % | BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 35,480 | -0,17 % | 12 Prozent bessere Testleistung: Wie ZEISS das Zusammenspiel von Brillenglas und Gehirn untersucht | ||
| PROGYNY | 28,130 | 0,00 % | Progyny, Inc.: New Progyny Study Finds Significant Improvement in Menopause Symptoms Through Connected Care Model | ||
| AVEANNA HEALTHCARE | 13,180 | 0,00 % | Biotech Stocks At 52-Week Highs - Park Dental Partners +10%, Aveanna Healthcare +24%, Candel Therapeutics +10% on Q2 Reports, Labcorp Holdings, Hemab Therapeutics | LONDON (dpa-AFX) - The following biotech stocks reached 52-week highs on August 13, 2026, driven by key catalysts such as positive quarterly reports and the issuance of increased guidance figures.Park... ► Artikel lesen |
NEXSTIM OYJ gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von +0,320 (+3,81 %) liegt der Kurs bei 8,720 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NEXSTIM OYJ finden Sie auf Wallstreet Online.